Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postoperative therapy modalities for cervical carcinoma.

Sherko Kümmel1, Anke Thomas, Sophia Jeschke

  • 1Department of Gynecology and Obstetrics, University Medicine Berlin, Charité Campus Mitte, Berlin, Germany. sherko.kuemmel@charite.de

Anticancer Research
|April 19, 2006
PubMed
Summary

Standard cervical cancer treatment involves radiochemotherapy, but toxicities can halt treatment. Research explores new therapies and supportive measures to improve survival and quality of life for patients with cervical carcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can acoustic structural quantification be used to characterize the ultrasound echotexture of the peripheral zone of breast lesions?

Clinical hemorheology and microcirculation·2019
Same author

The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.

Gynecologic oncology·2018
Same author

The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study.

BMC cancer·2018
Same author

Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.

PloS one·2018
Same author

Duration of storage influences the hemoglobin rising effect of red blood cells in patients undergoing major abdominal surgery.

Transfusion·2018
Same author

Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study.

Journal of cancer research and clinical oncology·2018

Area of Science:

  • Gynecologic Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • The standard treatment for FIGO stage IIB cervical carcinoma post-surgery is concurrent radiochemotherapy with platinum agents.
  • Adjuvant radiochemotherapy is also beneficial for FIGO stages IIA-IIB with specific risk factors.
  • Treatment-related toxicities can lead to therapy discontinuation, impacting patient outcomes.

Purpose of the Study:

  • To review current therapeutic strategies for cervical carcinoma.
  • To explore challenges associated with standard radiochemotherapy, including toxicity and prognostic factors like hemoglobin levels.
  • To discuss emerging therapies and supportive care interventions aimed at improving survival and quality of life.

Main Methods:

  • Review of existing scientific literature on cervical cancer treatment.

Related Experiment Videos

  • Analysis of data regarding treatment toxicities and prognostic factors.
  • Discussion of ongoing clinical trials investigating novel therapeutic approaches.

    • Main Results:

    • Platinum-based radiochemotherapy is feasible but associated with significant toxicities.
    • Low hemoglobin levels during treatment negatively impact overall survival.
    • Erythropoietin administration for hemoglobin increase shows contradictory survival data.

    Conclusions:

    • New cytostatics, combination chemotherapies, and sequential regimens are being investigated.
    • Supportive therapies are crucial for managing treatment-related toxicities.
    • Further research, including studies like Cervix-NOGGO-AGO-Uterus 7, is essential to evaluate new treatments for cervical cancer.